Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myelodysplastic Syndrome MDS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07672769
What this trial is testing

Bexmarilimab + Azacitidine Versus Placebo + Azacitidine in Participants With Treatment-naïve Higher-risk Myelodysplastic Syndromes

Who this might be right for
Higher Risk Myelodysplastic Syndromes
Faron Pharmaceuticals Ltd 90
Testing effectiveness (Phase 2)Study completedNCT00045396
What this trial is testing

A Phase II Study Of The Farnesyltransferase Inhibitor ZANESTRA (R115777, NSC #702818, IND #58,359) In Complete Remission Following Induction And/Or Consolidation Chemotherapy In Adults With Poor-Risk Acute Myelogenous Leukemia (AML) And High-Risk Myelodysplasia (MDS)

Who this might be right for
Adult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+6 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Ended earlyNCT01058369
What this trial is testing

Exjade-Early-Trial

Who this might be right for
Myelodysplastic Syndromes
University of Erlangen-Nürnberg Medical School 2
Early research (Phase 1)Active Not RecruitingNCT05552469
What this trial is testing

Dose Optimization and Expansion Study of DFV890 in Adult Patients With Myeloid Diseases

Who this might be right for
Myeloid Diseases
Novartis Pharmaceuticals 71
Testing effectiveness (Phase 2)Study completedNCT02044796
What this trial is testing

Filgrastim, Cladribine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes

Who this might be right for
Acute Biphenotypic Leukemiade Novo Myelodysplastic SyndromePreviously Treated Myelodysplastic Syndrome+3 more
Fred Hutchinson Cancer Center 199
Not applicableStudy completedNCT01041846
What this trial is testing

Dacogen Treatment in Patients With Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic Syndrome
Janssen Korea, Ltd., Korea 103
Testing effectiveness (Phase 2)Study completedNCT00776503
What this trial is testing

Vorinostat and Low Dose Cytarabine for High Risk Myelodysplasia

Who this might be right for
Myelodysplastic Syndromes
Groupe Francophone des Myelodysplasies 52
Early research (Phase 1)Active Not RecruitingNCT05362773
What this trial is testing

MGD024 in Patients With Relapsed or Refractory Hematologic Malignancies

Who this might be right for
Leukemia, Acute MyeloidMyelodysplastic SyndromesClassical Hodgkin Lymphoma+5 more
MacroGenics 130
Early research (Phase 1)Ended earlyNCT05209152
What this trial is testing

AMG 176 With Azacitidine in Subjects With Myelodysplastic Syndrome /Chronic Myelomonocytic Leukemia

Who this might be right for
Higher Risk Myelodysplastic SyndromeChronic Myelomonocytic Leukemia
Amgen 7
Large-scale testing (Phase 3)Looking for participantsNCT06756152
What this trial is testing

Preventing of GVHD with Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Ruxolitinib At Children and Young Adults with Hemoblastosis

Who this might be right for
Biphenotypic Acute LeukemiaAcute Lymphoblastic LeukemiaMyeloblastic Leukemia+3 more
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 50
Not applicableStudy completedNCT00900406
What this trial is testing

Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Vanderbilt-Ingram Cancer Center 190
Not applicableStudy completedNCT00996047
What this trial is testing

S9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
SWOG Cancer Research Network 3,341
Testing effectiveness (Phase 2)Study completedNCT04055844
What this trial is testing

Multi-Ctr PII Cmb.Modality Tx Ruxolitinib, Decitabine, and DLI for Post HSCT in AML/MDS

Who this might be right for
Acute Myeloid LeukemiaMyeloid and Monocytic LeukemiaMyelodysplastic Syndromes
Masonic Cancer Center, University of Minnesota 14
Not applicableLooking for participantsNCT06773871
What this trial is testing

Feasibility and Safety of Exercise in Patients With Low-risk Myeloid Cancers and Precursor Conditions

Who this might be right for
Myelodysplastic SyndromeCytopenia
Rigshospitalet, Denmark 36
Testing effectiveness (Phase 2)Ended earlyNCT01542684
What this trial is testing

Study of Azacytidine Followed by GM-CSF in Patients With Myelodysplastic Syndrome (MDS)

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 8
Early research (Phase 1)Ended earlyNCT00234000
What this trial is testing

Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Jonsson Comprehensive Cancer Center 1
Large-scale testing (Phase 3)Study completedNCT00469144
What this trial is testing

IV Busulfan With Allo-BMT: Study for Patients With Acute Myelogenous Leukemia and Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic SyndromeLeukemiaAcute Myeloid Leukemia
M.D. Anderson Cancer Center 233
Early research (Phase 1)Study completedNCT01378416
What this trial is testing

Pharmacokinetic Trial of Decitabine (Dacogen) Administered as a 3-hour Infusion to Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome

Who this might be right for
Leukemia
Eisai Inc. 16
Testing effectiveness (Phase 2)Ended earlyNCT03113071
What this trial is testing

Safety and Activity of Digoxin With Decitabine in Adult AML and MDS

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndromes
Fox Chase Cancer Center 1
Not applicableLooking for participantsNCT03016806
What this trial is testing

Umbilical Cord Blood Transplantation From Unrelated Donors

Who this might be right for
Acute LeukemiaImmune Deficiency DisorderCongenital Hematological Disorder+7 more
University of Rochester 30
Next Page
44